Medical Device Reading List (October 15, 2017)

Amidst multiple blows from natural disasters, $MDT has reason for optimism through $JNJ's exit from the insulin pump business. 

Natural disasters take their toll on Medtronic
Brad Perriello, Mass Device ($MDT)

Medtronic (MDT) Granted FDA Approval for Endurant II/IIs Stent Graft System
Street Insider ($MDT)

Johnson & Johnson Calls It Quits on Insulin Pumps Business
Kinsey Grant, The Street ($JNJ)

Baxter launches two studies of Theranova dialyzer
Douglas W. House, Seeking Alpha ($BAX)